NCT04065490 (LIGHTSITE III).

Study name	Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age‐Related Macular Degeneration (AMD) (LIGHTSITE III)
Methods	Double‐masked, randomised, sham‐controlled, parallel group, multi‐centre
Participants	Non‐exudative age‐related macular degeneration
Interventions	Experimental: the Valeda™ Light Delivery System Comparator: the sham mode of the Valeda™ Light Delivery System
Outcomes	Primary: best‐corrected visual acuity at 21 months Secondary: contrast sensitivity central drusen volume central drusen thickness Other: visual function questionnaire reading speed geographic atrophy low luminance ‐ best‐corrected visual acuity
Starting date	September 2019
Contact information	Clark Tedford ctedford@lumithera.com Cindy Croissant ccroissant@lumithera.com
Notes